Da Volterra

Developer of products to prevent bacterial infections triggered by antibiotic therapies

placeParis, Ile De France, France calendar_todayFounded 2000 groups16 employees language davolterra.com

Innovation

24 patent families (8 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing; filing pace slowing. Cited 1,221 times.

YearFilings
20127
20135
20143
20152
20162
20175
20184
20194
20205
20219
20227
20232

Investor mix

1 investor on record.

Investor typeCountShare
Private equity1100%
Coming soon